Where it comes from
- Made in
- Enteric neurons of the gut, and sensory neurons alongside alpha-CGRP
- Sent out by
- Gut and sensory nerve activity
- Acts on
- Gut vessels and smooth muscle
- Arteries
What it does
In medicine
- The migraine medicines bind it as well as alpha-CGRP, so both should fall under treatment; in treated patients only the alpha level does 1
- Assays that tell the two apart exist only in research, and the blood has to be drawn into protease inhibitors for either to be read reliably 2
- No condition is diagnosed by its level and no medicine is aimed at it alone
Beyond the body’s own use
- It is hardly ever studied apart from alpha-CGRP, which is why its own job is still open 4
- As the CGRP of the gut’s own nerves it has been looked for in bowel disease: people newly diagnosed with inflammatory bowel disease carried lower blood levels than healthy controls in the one study that measured it 3
- Nobody takes it and nothing copies it; the question being asked is whether a blocker that spared beta-CGRP would spare the gut
Sources
- Gárate et al., Serum alpha- and beta-CGRP in chronic migraine before and after CGRP antibodies, Annals of Neurology 2023
- de la Guerra-Sasián et al., Improving alpha- and beta-CGRP measurement in plasma, International Journal of Molecular Sciences 2025
- Pascual-Mato et al., Beta-CGRP in inflammatory bowel disease, BMC Gastroenterology 2024
- Russell et al., Calcitonin gene-related peptide: physiology and pathophysiology, Physiological Reviews 2014
This card describes what a medicine is for and what the evidence says; it recommends nothing. Talk to your clinician about anything you read here.